Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Melanoma Res ; 12(5): 471-7, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12394189

RESUMEN

5-S-cysteinyldopa (5-S-CD) has been described as a tumour marker for the detection of human metastatic melanoma. We investigated the clinical utility of a new and optimized method to detect 5-S-CD by analysing 207 plasma samples derived from 138 patients with clinical stage I/II ( = 60), III ( = 32) or IV ( = 46) melanoma. Control groups consisted of 27 patients with non-melanoma skin diseases and 30 healthy volunteers. 5-S-CD plasma levels were determined using a new analytical technique based on a fully automated solid phase extraction coupled online to a novel high performance liquid chromatography method. In all the samples from the healthy control subjects 5-S-CD plasma concentrations were below 2.0 microg/l. Increased 5-S-CD-levels (>/=2.0 microg/l) were found in 52%, 67% and 81% of the plasma samples from patients with stages I/II, III and IV malignant melanoma, respectively. The mean values of 5-S-CD were found to rise with increasing tumour stage. Among 27 samples from patients with non-melanoma skin disease, slightly elevated 5-S-CD levels between 2.3 and 2.6 microg/l were found in only four samples from patients with multiple dysplastic naevi. In conclusion, our improved analytical technique provides a high sensitivity in all stages of the disease and represents a useful technique for monitoring melanoma patients.


Asunto(s)
Biomarcadores de Tumor , Cisteinildopa/sangre , Melanoma/sangre , Melanoma/metabolismo , Estudios de Casos y Controles , Cromatografía Líquida de Alta Presión , Progresión de la Enfermedad , Femenino , Humanos , Masculino , Melanoma/diagnóstico , Pronóstico , Sensibilidad y Especificidad
2.
J Chromatogr B Biomed Sci Appl ; 764(1-2): 409-43, 2001 Nov 25.
Artículo en Inglés | MEDLINE | ID: mdl-11817040

RESUMEN

Malignant melanoma is a skin tumour, which carries a very unfavourable prognosis. The early detection of a melanoma and even more its metastasis is of decisive importance for the survival prognosis of the patients. So there is always a desire for simple, economical and meaningful serological markers. From the cysteine- and indole-related derivatives, 5-S-cysteinyldopa (5-SCD) and 6-hydroxy-5-methoxy-indole-2-carboxylic acid (6H5MI2C) are the most important substances for this purpose. For 5-SCD, the sample pretreatment was carried out either by a manual extraction onto alumina, by an automated method onto boronic acid affinity gels or by an automated solid-phase extraction. For 6H5MI2C, liquid-liquid extractions or direct injection techniques were applied. The chromatographic analyses in the early years were mostly performed with GC-MS. Today HPLC is the nearly exclusively used separation technique. For HPLC, standard RP18 separating columns and usual compositions of eluents were applied. As detectors both the ECD and the FD showed a sufficient sensitivity and selectivity. 5-SCD and 6H5MI2C are very sensitive to light and oxidation. These properties must be taken into account in the complete analysis procedure, including the sample collection, otherwise false low values will result especially for plasma samples. For a critical discussion of the analytical methods and still more for the interpretation of the obtained results, the detailed analytical procedures must be considered. 5-SCD in plasma is one of the best markers of malignant melanoma. It shows an excellent specificity and also an adequate sensitivity in the metastatic melanoma stages. For the detection of primary melanomas and for urine instead of plasma samples, the sensitivity of 5-SCD is generally lower. Altogether, the sensitivity of this parameter is not yet sufficient. 6H5MI2C and other indole derivatives have been investigated far less than 5-SCD. 6H5MI2C correlates less clearly with the different stages of the melanoma and is therefore a less suitable marker. To improve the sensitivity of the findings, in future the investigations should be performed as multi-marker analysis with the simultaneous measurements of more than one marker substance in a given patient sample. Not only one measurement should be carried out per patient, it would be more meaningful to observe the patients with laboratory diagnostics in the follow-up.


Asunto(s)
Biomarcadores de Tumor/metabolismo , Cisteína/metabolismo , Indoles/metabolismo , Melanoma/metabolismo , Neoplasias Cutáneas/metabolismo , Cromatografía/métodos , Cromatografía de Gases y Espectrometría de Masas , Humanos , Estándares de Referencia
3.
J Chromatogr B Biomed Sci Appl ; 727(1-2): 31-42, 1999 Apr 30.
Artículo en Inglés | MEDLINE | ID: mdl-10360420

RESUMEN

5-S-Cysteinyldopa (5-SCD) in plasma and urine was determined by means of a newly developed method. This method incorporates optimized conditions for blood collection and storage, as well as a new extraction and separation technique, required for the strong oxidation and light sensitive 5-SCD. The new aspects of the method are the following: immediate centrifugation and freezing of the samples after blood collection, fully automatical solid-phase extraction (SPE) with phenylboronic acid (PBA) cartridges and immediate HPLC injection of the eluate, nearly complete exclusion of light and air-oxygen during extraction, constant sample cooling, use of the more suitable internal standard 5-S-D-cysteinyldopa and easy, sensitive and selective HPLC conditions (RP18-column with isocratic separation and electrochemical detection). The method has a linear range from 0.25 to 50 microg l(-1) and 25 to 5000 microg l(-1) for plasma and urine samples, respectively, a limit of detection of 0.17 microg l(-1), intra-assay variabilities from 1.7 to 3.6%, inter-assay variabilities from 4.0 to 18.3% and an average relative recovery of 103.5% for plasma and 105.4% for urine samples. In our study the measured 5-SCD concentrations of patients with melanomas at various stages correlated better with their clinical pictures than described in literature up to date. The results were obtained in comparison to patients with other skin tumors and in comparison to healthy control persons.


Asunto(s)
Biomarcadores de Tumor/metabolismo , Cromatografía Líquida de Alta Presión/métodos , Cisteinildopa/metabolismo , Melanoma/fisiopatología , Neoplasias Cutáneas/metabolismo , Automatización , Biomarcadores de Tumor/sangre , Biomarcadores de Tumor/orina , Calibración , Estudios de Casos y Controles , Cisteinildopa/sangre , Cisteinildopa/orina , Humanos , Melanoma/sangre , Melanoma/orina , Pronóstico , Estándares de Referencia , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Neoplasias Cutáneas/sangre , Neoplasias Cutáneas/orina
4.
Dig Dis Sci ; 42(11): 2356-66, 1997 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9398817

RESUMEN

We have shown that the contact (kallikrein-kinin) system is involved in the pathogenesis of experimental enterocolitis. We now investigate activation of the contact and coagulation pathways, platelets, and neutrophils in active and inactive ulcerative colitis patients as compared to normal controls. In active ulcerative colitis patients, a significant decrease of plasma prekallikrein, high molecular weight kininogen, and C1 inhibitor levels was observed as compared with controls, as well as prekallikrein activation on western blots. Significant elevation of prothrombin fragment (F1 + 2), which indicates thrombin generation, and elastase-alpha 1-antitrypsin complexes, reflecting neutrophil activation, were found in patients with active disease. Plasma beta-thromboglobulin, a marker of platelet activation, was elevated in both active and inactive disease and appears to be a feature of ulcerative colitis. Activation of contact and coagulation pathways, as well as neutrophils, may mediate inflammation in the active phase of ulcerative colitis.


Asunto(s)
Colitis Ulcerosa/fisiopatología , Sistema Calicreína-Quinina , Activación Neutrófila , Activación Plaquetaria , Adulto , Coagulación Sanguínea/fisiología , Western Blotting , Femenino , Fibrinólisis/fisiología , Humanos , Masculino , Precalicreína/análisis , beta-Tromboglobulina/análisis
6.
J Chromatogr ; 622(2): 161-71, 1993 Dec 22.
Artículo en Inglés | MEDLINE | ID: mdl-7512090

RESUMEN

A method is described for the simultaneous determination of vanilmandelic acid, 3-methoxy-4-hydroxyphenylethylene glycol, 5-hydroxyindoleacetic acid, and homovanillic acid in a human plasma sample using reversed-phase high-performance liquid chromatography with column switching and amperometric detection. Two methods of sample preparation were tested. Liquid-liquid extraction yields better recoveries, is more selective and precise than solid-phase extraction and allows a shorter time of chromatographic analysis. Estimated plasma values of the metabolites from healthy controls are in good agreement with previously reported levels. Studies of alcoholics at the beginning of the delirium tremens provided different plasma levels of the metabolites, dependent on the different duration--and hence the severity--of the delirium.


Asunto(s)
Alcoholismo/sangre , Monoaminas Biogénicas/sangre , Delirio por Abstinencia Alcohólica/sangre , Cromatografía Líquida de Alta Presión , Electroquímica , Ácido Homovanílico/sangre , Humanos , Ácido Hidroxiindolacético/sangre , Indicadores y Reactivos , Metoxihidroxifenilglicol/sangre , Ácido Vanilmandélico/sangre
7.
Klin Oczna ; 94(10): 285-6, 1992 Oct.
Artículo en Polaco | MEDLINE | ID: mdl-1339121

RESUMEN

Ophthalmoscopic examinations were performed in 96 patients with polyps or another disturbances of the colon, among them 3 cases suffered a histopathologically confirmed familial polyposis of the colon. All 3 cases of the familial polyposis exhibited in the ophthalmological examination pathological changes of the retinal pigment epithelium of both eyes.


Asunto(s)
Poliposis Adenomatosa del Colon/complicaciones , Epitelio Pigmentado Ocular/patología , Adulto , Humanos , Hipertrofia , Masculino , Persona de Mediana Edad , Oftalmoscopía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA